argenx SE (ARGNF)
OTCMKTS · Delayed Price · Currency is USD
833.50
0.00 (0.00%)
At close: Oct 6, 2025
argenx SE Employees
argenx SE had 1,599 employees as of December 31, 2024. The number of employees increased by 451 or 39.29% compared to the previous year.
Employees
1,599
Change (1Y)
451
Growth (1Y)
39.29%
Revenue / Employee
$1,951,733
Profits / Employee
$800,749
Market Cap
48.86B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,599 | 451 | 39.29% |
| Dec 31, 2023 | 1,148 | 305 | 36.18% |
| Dec 31, 2022 | 843 | 193 | 29.69% |
| Dec 31, 2021 | 650 | 314 | 93.45% |
| Dec 31, 2020 | 336 | 150 | 80.55% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Elite Pharmaceuticals | 68 |
| Glass House Brands | 374 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| American Oncology Network | 1,914 |
| Silence Therapeutics | 116 |
| Jushi Holdings | 1,234 |
| Nuo Therapeutics | 9 |
argenx SE News
- 6 days ago - argenx announces Extraordinary General Meeting of Shareholders on November 18, 2025 - GlobeNewsWire
- 8 days ago - Morgan Stanley Raises Price Target for ARGX to $1040 While Maintaining Overweight Rating | ARGX ... - GuruFocus
- 9 days ago - INCY vs. ARGX: Which Stock Is the Better Value Option? - Nasdaq
- 10 days ago - Here's How Much $100 Invested In argenx 5 Years Ago Would Be Worth Today - Benzinga
- 13 days ago - Price Over Earnings Overview: argenx - Benzinga
- 21 days ago - Guggenheim Reiterates Buy Rating for ARGX with Target Price of $1070 | ARGX Stock News - GuruFocus
- 21 days ago - FUJIFILM Biotechnologies Expands Strategic Partnership with argenx to Include U.S. Manufacturing Operations - Business Wire
- 23 days ago - argenx SE - Special Call - Seeking Alpha